NCT05823103

Brief Summary

Comparing surgical outcomes of Hysteroscopic metroplasty for uterine septum when using the standard ESGE or ASRM classifications vs the novel scoring system dubbed Shawki Septum Scoring System. Outcomes based primarily on completion of the septal correction (no residual parts) and avoiding complications, the most significant of which are uterine perforation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 18, 2018

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 21, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

5 years

First QC Date

March 27, 2023

Last Update Submit

April 8, 2023

Conditions

Keywords

HysterscopyCongenital Uterine AnomalyUterine SeptumSeptet UterusNovel Scoring SystemShawki Septum Scoring System

Outcome Measures

Primary Outcomes (2)

  • Number of patients with Complete Septum Correction

    No residual septum on 3D ultrasound

    1 month

  • Percentage of patients who had an intra-operative Uterine perforation

    Diminishing the risk of intra-operative perforation of the fundus

    during the surgery

Study Arms (2)

Hysteroscopic Metroplasty using ESHRE ASRM Classification

ACTIVE COMPARATOR
Diagnostic Test: ESHRE ASRM Classification

Hysteroscopic Metroplasty using Shawki Septum Scoring System

ACTIVE COMPARATOR
Diagnostic Test: Shawki Septum Scoring System

Interventions

Utilising the novel scoring system to facilitate feasibility and safety of hysteroscopic metroplasty for uterine septum

Hysteroscopic Metroplasty using Shawki Septum Scoring System

Utilising the current classification before performing hysteroscopic metroplasty

Hysteroscopic Metroplasty using ESHRE ASRM Classification

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Uterine Septum diagnosed by 3D ultrasound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shifa Hospital

Cairo, 11835, Egypt

RECRUITING

Related Publications (6)

  • Rikken JFW, Kowalik CR, Emanuel MH, Bongers MY, Spinder T, de Kruif JH, Bloemenkamp KWM, Jansen FW, Veersema S, Mulders AGMGJ, Thurkow AL, Hald K, Mohazzab A, Khalaf Y, Clark TJ, Farrugia M, van Vliet HA, Stephenson MS, van der Veen F, van Wely M, Mol BWJ, Goddijn M. The randomised uterine septum transsection trial (TRUST): design and protocol. BMC Womens Health. 2018 Oct 5;18(1):163. doi: 10.1186/s12905-018-0637-6.

  • Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril. 2016 Sep 1;106(3):530-40. doi: 10.1016/j.fertnstert.2016.05.014. Epub 2016 May 25.

  • Alcazar JL, Carriles I, Cajas MB, Costa S, Fabra S, Cabrero M, Castro E, Tomaizeh A, Laza MV, Monroy A, Martinez I, Aguilar MI, Hernani E, Castellet C, Oliva A, Pascual MA, Guerriero S. Diagnostic Performance of Two-Dimensional Ultrasound, Two-Dimensional Sonohysterography and Three-Dimensional Ultrasound in the Diagnosis of Septate Uterus-A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2023 Feb 20;13(4):807. doi: 10.3390/diagnostics13040807.

  • Rikken JFW, Kowalik CR, Emanuel MH, Bongers MY, Spinder T, Jansen FW, Mulders AGMGJ, Padmehr R, Clark TJ, van Vliet HA, Stephenson MD, van der Veen F, Mol BWJ, van Wely M, Goddijn M. Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial. Hum Reprod. 2021 Apr 20;36(5):1260-1267. doi: 10.1093/humrep/deab037.

  • Nouri K, Ott J, Huber JC, Fischer EM, Stogbauer L, Tempfer CB. Reproductive outcome after hysteroscopic septoplasty in patients with septate uterus--a retrospective cohort study and systematic review of the literature. Reprod Biol Endocrinol. 2010 May 21;8:52. doi: 10.1186/1477-7827-8-52.

  • Agostini A, Bretelle F, Cravello L, Ronda I, Roger V, Blanc B. [Complications of operative hysteroscopy]. Presse Med. 2003 May 24;32(18):826-9. French.

MeSH Terms

Conditions

Septate UterusUterine Anomalies

Condition Hierarchy (Ancestors)

Uterine Duplication AnomaliesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Yehia Shawki, MRCOG

    Endo-Planet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yehia Shawki, MRCOG

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Endoscopy Unit

Study Record Dates

First Submitted

March 27, 2023

First Posted

April 21, 2023

Study Start

November 18, 2018

Primary Completion

November 30, 2023

Study Completion

December 30, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
1 year following completion

Locations